Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Finasteride reduces some inflammation in BPH but not all.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

A vitamin D receptor mutation causes rickets and affects immune responses.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Hidradenitis suppurativa might be a type of autoinflammatory skin disease.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.

Targeting regulatory T cells may help treat age-related diseases.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.